Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00463047Phase 3Completed
A Phase 3 trial of fentanyl in breakthrough pain, sponsored by Cephalon, Inc.. Started Jul 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00463047.